Arteris, Inc. (NASDAQ:AIP) CEO Sells $39,633.60 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 5,520 shares of Arteris stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $7.18, for a total transaction of $39,633.60. Following the transaction, the chief executive officer now owns 287,247 shares in the company, valued at $2,062,433.46. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

K Charles Janac also recently made the following trade(s):

• On Thursday, September 5th, K Charles Janac sold 1,955 shares of Arteris stock. The stock was sold at an average price of $7.26, for a total transaction of $14,193.30.
• On Tuesday, September 3rd, K Charles Janac sold 1,348 shares of Arteris stock. The shares were sold at an average price of $7.87, for a total value of $10,608.76.

Arteris Price Performance

Shares of AIP stock opened at $7.10 on Friday. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.17. The firm’s fifty day moving average price is $7.52 and its two-hundred day moving average price is $7.64. The firm has a market capitalization of $273.20 million, a P/E ratio of -6.89 and a beta of 1.11. Arteris, Inc. has a 1 year low of $4.20 and a 1 year high of $9.54.

Arteris (NASDAQ:AIP) last issued its quarterly earnings data on Thursday, August 1st. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.07). The firm had revenue of $14.58 million for the quarter, compared to the consensus estimate of $13.68 million. Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. During the same quarter in the prior year, the firm earned ($0.25) EPS. On average, equities analysts predict that Arteris, Inc. will post -0.9 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on AIP shares. Rosenblatt Securities restated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a report on Monday, August 5th. Westpark Capital restated a “buy” rating and set a $11.00 price target on shares of Arteris in a research note on Wednesday, July 31st.

Institutional Investors Weigh In On Arteris

Several hedge funds have recently modified their holdings of AIP. The Manufacturers Life Insurance Company bought a new stake in shares of Arteris during the 2nd quarter valued at about $86,000. Algert Global LLC purchased a new stake in Arteris during the second quarter worth about $115,000. Rhumbline Advisers grew its holdings in Arteris by 2,182.8% during the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock valued at $239,000 after purchasing an additional 30,428 shares during the period. CloudAlpha Capital Management Limited Hong Kong bought a new position in Arteris during the second quarter worth about $554,000. Finally, Bank of New York Mellon Corp bought a new stake in Arteris during the 2nd quarter valued at $580,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.